2Lee NS, Dohjima T, Bauer G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol,2002,20: 500-505.
3Novina CD, Murray MF, Dykxhoom DM, et al. siRNA-directed inhibition of HIV- 1 infection. Nat Med, 2002,8: 681-686.
4Jacque JM,Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature, 2002,418: 435-438.
5Yamamoto T, Omoto S, Mizuguchi M, et al. Double-stranded nef RNA intefferes with human immunodeficiency virus type 1 replication. Microbiol.Immunol, 2002,46: 809-817.
6Xia H, Mao Q, Paulson HL, et al. SiRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol,2002,20:1006-1010.
7Ramezani A, Marhin W. Weerasinghe M, et al. A rapid and efficient system for screening HIV-1 pol mRNA-specific ribozymes . Can J Microbiol,1997,43(1):92-96.
8Wang L, Witherington C, King A, et al. Prechnical characterization of an anti-tat ribozyme for therapeutic application. Hum Gene Ther, 1998, 9(9): 1283-1291.
9Klebba C, Ottmann OG, Scher M. et al. Retrovirally express anti-HlV ribozymes confer a selective survival advantage on CD4+ T cells in vitro.Gene Ther,2000,7(5) :408-416.
10Feng Y, Leavitt M, Tritz R, et al. Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5.Virology,2000,276(2): 271-278.
